Yes, but the results from that trial have already been released to the public. They have already had poster presentations on it for example.
There is nothing new in this paper. It just publishes that information in a journal which is more prestigious. There is no new information here.
- Forums
- ASX - By Stock
- BIT
- Major Article - BIT225, in combination with 3-drug antiretroviral therapy
Major Article - BIT225, in combination with 3-drug antiretroviral therapy, page-17
-
- There are more pages in this discussion • 205 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
2.6¢ |
Change
-0.001(3.70%) |
Mkt cap ! $23.46M |
Open | High | Low | Value | Volume |
2.7¢ | 2.7¢ | 2.6¢ | $8.415K | 322.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 37530 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.026 |
7 | 804946 | 0.025 |
2 | 3453333 | 0.024 |
1 | 130000 | 0.023 |
4 | 825000 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 37530 | 1 |
0.028 | 145600 | 2 |
0.029 | 260000 | 2 |
0.030 | 49844 | 3 |
0.031 | 280868 | 5 |
Last trade - 15.23pm 16/08/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |